Jacek Mackiewicz

机构：Poznan University of Medical Sciences · ORCID：0000-0002-0177-2972

发表论文 106 篇 · 总被引 2485 次 · h-index 20

代表论文

• Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Long-term follow-up, crossover, and rechallenge with pembrolizumab in the phase III KEYNOTE-716 study (2025 · European Journal of Cancer · 被引 17)
• lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients (2025 · Biomedicines · 被引 5)
• Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy (2025 · International Journal of Molecular Sciences · 被引 2)
• MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition (2026 · Clinical Cancer Research · 被引 1)
• Encorafenib with binimetinib efficacy in the first, second, and third line of treatment for patients with advanced melanoma harboring a BRAF mutation — real-world study (2025 · Oncology in Clinical Practice · 被引 1)
• 1682P Outcomes of first-, second- and third-line treatment with all available combinations of BRAF plus MEK inhibitors in advanced melanoma patients: A real-world study (2025 · Annals of Oncology · 被引 1)